• Rheumatology nurses key to dispelling misinformation over off-label therapies

    7 monthes ago - By Healio

    FORT WORTH, Texas - Although rheumatology providers carry the responsibility of obtaining informed consent for the use of off-label treatments, nurses should help educate patients, particularly the parents or guardians of juvenile patients, on the justification of off-label therapies, according to presenters at the Rheumatology Nurses Society Annual Conference.
    “I'm going to use the FDA's own words here: ‘Once the FDA approves a drug, health care providers generally may prescribe the drug for an unapproved use if they judge it is medically appropriate for the patient,'”
    Read more ...